Semaglutide
STEP 6
Novo Nordisk · Phase 3 · Completed · Enrollment 401
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Semaglutide 2.4 mg | Obesity or overweight | 2.4 mg | 68 | ITT | n/r |
| Placebo (semaglutide 2.4 mg) | Obesity or overweight | 2.4 mg | 68 | ITT | n/r |
| Semaglutide 1.7 mg | Obesity or overweight | 1.7 mg | 68 | ITT | n/r |
| Placebo (semaglutide 1.7 mg) | Obesity or overweight | 1.7 mg | 68 | n/r | n/r |